Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant

Dayal, S; Aluri, J; Hall, N; Filippov, G; Moline, M; Reyderman, L; Landry, I

Landry, I (corresponding author), Eisai Inc, 100 Tice Blvd, Woodcliff Lake, NJ 07677 USA.

PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021; 9 (2):

Abstract

Lemborexant, a dual orexin receptor antagonist, is approved in the United States, Japan, and Canada for the treatment of insomnia in adults. This phas......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索